Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35855184e8b812a058f885cfd2dcf57f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H70-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-20 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H40-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H70-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H70-40 |
filingDate |
2018-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c05ed09e5c88fd901e5a627ab49ffaa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c65566998696294673d9d8b70451ccd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bce3ad98d5acb44b4e7051b4fca9184 |
publicationDate |
2022-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11456081-B1 |
titleOfInvention |
Sensitive drug distribution systems and methods |
abstract |
A drug distribution system and method utilizes a central pharmacy and database to track all prescriptions for a sensitive drug. Information is kept in the database regarding all physicians allowed to prescribe the sensitive drug, and all patients receiving the drug. Abuses are identified by monitoring data in the database for prescription patterns by physicians and prescriptions obtained by patients and/or caregivers. Further verification is made that the physician is eligible to prescribe the drug by consulting a separate database, and optionally whether any actions are taken against the physician. Multiple controls beyond those for normal drugs are imposed on the distribution depending on the sensitivity of the drug. |
priorityDate |
2017-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |